Medley is the third largest pharmaceutical company in Brazil, specializing in the production of generic medicines. Since its establishment in 1996, the company has achieved significant success in the pharmaceutical industry, with BR$ 458 million in sales in 2009. With two manufacturing plants in Campinas/SP and Sumaré/SP, Medley offers a diverse range of pharmaceutical products, including pills, capsules, liquids, and creams.
One of Medley's key strengths lies in its coherent management style, commitment to social projects, and robust Human Resources policy, supporting the personal and professional development of its approximately 1,500 employees. The company has been recognized as one of the best places to work in Brazil by Guia Exame for six consecutive years, from 2002 to 2008.
Despite not having the latest investment details available, Medley's proven track record and leadership position in the Brazilian pharmaceutical market make it an attractive prospect for potential investors. The company's strong performance in the manufacturing and pharmaceutical sectors, coupled with its focus on corporate social responsibility, positions it as an appealing opportunity for investment in the burgeoning Brazilian pharmaceutical market.
There is no investment information
No recent news or press coverage available for Medley.